Off Patent
March 2026

Arnuity Ellipta

fluticasone furoate

Glaxosmithkline Intellectual Property Development Ltd England

Powder (inhalation) · NDA 205625

Last listed protection ended
March 1, 2026

The FDA listed 1 exclusivity for Arnuity Ellipta, and this is the day the last one ended. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Ended
    Other exclusivity
    FDA code M-290